Citigroup’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-3,487
| Closed | -$18K | – | 5648 |
|
2022
Q2 | $18K | Buy |
3,487
+2,585
| +287% | +$13.3K | ﹤0.01% | 4381 |
|
2022
Q1 | $11K | Sell |
902
-2,058
| -70% | -$25.1K | ﹤0.01% | 4713 |
|
2021
Q4 | $58K | Buy |
2,960
+1,586
| +115% | +$31.1K | ﹤0.01% | 4226 |
|
2021
Q3 | $36K | Buy |
1,374
+604
| +78% | +$15.8K | ﹤0.01% | 4184 |
|
2021
Q2 | $17K | Sell |
770
-39,230
| -98% | -$866K | ﹤0.01% | 4729 |
|
2021
Q1 | $936K | Buy |
+40,000
| New | +$936K | ﹤0.01% | 2435 |
|
2020
Q1 | – | Sell |
-116
| Closed | -$1K | – | 5251 |
|
2019
Q4 | $1K | Hold |
116
| – | – | ﹤0.01% | 5065 |
|
2019
Q3 | $2K | Sell |
116
-39
| -25% | -$672 | ﹤0.01% | 4981 |
|
2019
Q2 | $4K | Sell |
155
-124
| -44% | -$3.2K | ﹤0.01% | 4940 |
|
2019
Q1 | $10K | Buy |
279
+8
| +3% | +$287 | ﹤0.01% | 4765 |
|
2018
Q4 | $12K | Buy |
271
+17
| +7% | +$753 | ﹤0.01% | 4585 |
|
2018
Q3 | $35K | Buy |
254
+122
| +92% | +$16.8K | ﹤0.01% | 4293 |
|
2018
Q2 | $62K | Buy |
+132
| New | +$62K | ﹤0.01% | 3734 |
|